These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 33962926

  • 1. Rare case of a duodenal de novo dedifferentiated gastrointestinal stromal tumour.
    Shah PA, Babu R, Uthaiah SB, Patil S.
    BMJ Case Rep; 2021 May 07; 14(5):. PubMed ID: 33962926
    [Abstract] [Full Text] [Related]

  • 2. Effect of KIT and PDGFRA Mutations on Survival in Patients With Gastrointestinal Stromal Tumors Treated With Adjuvant Imatinib: An Exploratory Analysis of a Randomized Clinical Trial.
    Joensuu H, Wardelmann E, Sihto H, Eriksson M, Sundby Hall K, Reichardt A, Hartmann JT, Pink D, Cameron S, Hohenberger P, Al-Batran SE, Schlemmer M, Bauer S, Nilsson B, Kallio R, Junnila J, Vehtari A, Reichardt P.
    JAMA Oncol; 2017 May 01; 3(5):602-609. PubMed ID: 28334365
    [Abstract] [Full Text] [Related]

  • 3. Clinical implications of KIT and PDGFRA genotyping in GIST.
    Martín-Broto J, Rubio L, Alemany R, López-Guerrero JA.
    Clin Transl Oncol; 2010 Oct 01; 12(10):670-6. PubMed ID: 20947481
    [Abstract] [Full Text] [Related]

  • 4. Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours.
    Lasota J, Miettinen M.
    Histopathology; 2008 Sep 01; 53(3):245-66. PubMed ID: 18312355
    [Abstract] [Full Text] [Related]

  • 5. Tyrosine-kinase mutations in c-KIT and PDGFR-alpha genes of imatinib naïve adult patients with gastrointestinal stromal tumours (GISTs) of the stomach and small intestine: relation to tumour-biological risk-profile and long-term outcome.
    Søreide K, Sandvik OM, Søreide JA, Gudlaugsson E, Mangseth K, Haugland HK.
    Clin Transl Oncol; 2012 Aug 01; 14(8):619-29. PubMed ID: 22855146
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic significance of DOG-1 and PKC-θ expression and c-Kit/PDGFRA mutations in gastrointestinal stromal tumours.
    Wang C, Jin MS, Zou YB, Gao JN, Li XB, Peng F, Wang HY, Wu ZD, Wang YP, Duan XM.
    Scand J Gastroenterol; 2013 Sep 01; 48(9):1055-65. PubMed ID: 23862765
    [Abstract] [Full Text] [Related]

  • 7. Remarkable effects of imatinib in a family with young onset gastrointestinal stromal tumors and cutaneous hyperpigmentation associated with a germline KIT-Trp557Arg mutation: case report and literature overview.
    Farag S, van der Kolk LE, van Boven HH, van Akkooi ACJ, Beets GL, Wilmink JW, Steeghs N.
    Fam Cancer; 2018 Apr 01; 17(2):247-253. PubMed ID: 28710566
    [Abstract] [Full Text] [Related]

  • 8. Dedifferentiation in gastrointestinal stromal tumor to an anaplastic KIT-negative phenotype: a diagnostic pitfall: morphologic and molecular characterization of 8 cases occurring either de novo or after imatinib therapy.
    Antonescu CR, Romeo S, Zhang L, Nafa K, Hornick JL, Nielsen GP, Mino-Kenudson M, Huang HY, Mosquera JM, Dei Tos PA, Fletcher CD.
    Am J Surg Pathol; 2013 Mar 01; 37(3):385-92. PubMed ID: 23348204
    [Abstract] [Full Text] [Related]

  • 9. Platelet-Derived Growth Factor Receptor-α Regulates Proliferation of Gastrointestinal Stromal Tumor Cells With Mutations in KIT by Stabilizing ETV1.
    Hayashi Y, Bardsley MR, Toyomasu Y, Milosavljevic S, Gajdos GB, Choi KM, Reid-Lombardo KM, Kendrick ML, Bingener-Casey J, Tang CM, Sicklick JK, Gibbons SJ, Farrugia G, Taguchi T, Gupta A, Rubin BP, Fletcher JA, Ramachandran A, Ordog T.
    Gastroenterology; 2015 Aug 01; 149(2):420-32.e16. PubMed ID: 25865047
    [Abstract] [Full Text] [Related]

  • 10. Molecular characterization of an Italian series of sporadic GISTs.
    Origone P, Gargiulo S, Mastracci L, Ballestrero A, Battistuzzi L, Casella C, Comandini D, Cusano R, Dei Tos AP, Fiocca R, Garuti A, Ghiorzo P, Martinuzzi C, Toffolatti L, Liguria GIST Unit, Bianchi Scarrà G.
    Gastric Cancer; 2013 Oct 01; 16(4):596-601. PubMed ID: 23291969
    [Abstract] [Full Text] [Related]

  • 11. KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs).
    Lasota J, Miettinen M.
    Semin Diagn Pathol; 2006 May 01; 23(2):91-102. PubMed ID: 17193822
    [Abstract] [Full Text] [Related]

  • 12. Characterizing gastrointestinal stromal tumors and evaluating neoadjuvant imatinib by sequencing of endoscopic ultrasound-biopsies.
    Hedenström P, Nilsson B, Demir A, Andersson C, Enlund F, Nilsson O, Sadik R.
    World J Gastroenterol; 2017 Aug 28; 23(32):5925-5935. PubMed ID: 28932084
    [Abstract] [Full Text] [Related]

  • 13. Identifying Secondary Mutations in Chinese Patients with Imatinib-Resistant Gastrointestinal Stromal Tumors (GISTs) by Next Generation Sequencing (NGS).
    Du J, Wang S, Wang R, Wang SY, Han Q, Xu HT, Yang P, Liu Y.
    Pathol Oncol Res; 2020 Jan 28; 26(1):91-100. PubMed ID: 31758409
    [Abstract] [Full Text] [Related]

  • 14. Concomitant KIT/BRAF and PDGFRA/BRAF mutations are rare events in gastrointestinal stromal tumors.
    Rossi S, Sbaraglia M, Dell'Orto MC, Gasparotto D, Cacciatore M, Boscato E, Carraro V, Toffolatti L, Gallina G, Niero M, Pilozzi E, Mandolesi A, Sessa F, Sonzogni A, Mancini C, Mazzoleni G, Romeo S, Maestro R, Dei Tos AP.
    Oncotarget; 2016 May 24; 7(21):30109-18. PubMed ID: 27097112
    [Abstract] [Full Text] [Related]

  • 15. Molecular analysis of secondary kinase mutations in imatinib-resistant gastrointestinal stromal tumors.
    Lim KH, Huang MJ, Chen LT, Wang TE, Liu CL, Chang CS, Liu MC, Hsieh RK, Tzen CY.
    Med Oncol; 2008 May 24; 25(2):207-13. PubMed ID: 18488160
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Gastrointestinal stromal tumors - Summary of mutational status of the primary/secondary KIT/PDGFRA mutations, BRAF mutations and SDH defects.
    Kalfusova A, Linke Z, Kalinova M, Krskova L, Hilska I, Szabova J, Vicha A, Kodet R.
    Pathol Res Pract; 2019 Dec 24; 215(12):152708. PubMed ID: 31708372
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Imatinib treatment for gastrointestinal stromal tumour (GIST).
    Lopes LF, Bacchi CE.
    J Cell Mol Med; 2010 Jan 24; 14(1-2):42-50. PubMed ID: 19968734
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.